OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma
Xiong Lei, Yunfeng Li, Guodong Chen, et al.
Oncotarget (2015) Vol. 6, Iss. 38, pp. 40622-40641
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment
Yu‐Tzu Tai, Chirag Acharya, Gang An, et al.
Blood (2016) Vol. 127, Iss. 25, pp. 3225-3236
Open Access | Times Cited: 294

Small molecule agents for triple negative breast cancer: Current status and future prospects
Yan Ou, Mengchao Wang, Qian Xu, et al.
Translational Oncology (2024) Vol. 41, pp. 101893-101893
Open Access | Times Cited: 13

Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates
Xinghua Xiao, Linchen Lv, Jing Duan, et al.
Molecules (2018) Vol. 23, Iss. 4, pp. 787-787
Open Access | Times Cited: 52

Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes
Nicole Kiweler, Desirée Wünsch, Matthias Wirth, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 2, pp. 343-356
Open Access | Times Cited: 46

Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
Jinhong Zhu, Yang Liu, Haijiao Ao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27

Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort
Kiran K. Mangalaparthi, Krishna Patel, Aafaque Ahmad Khan, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 27

KAT2A/E2F1 Promotes Cell Proliferation and Migration via Upregulating the Expression of UBE2C in Pan-Cancer
Shudai Lin, Qiu Li, Keying Liang, et al.
Genes (2022) Vol. 13, Iss. 10, pp. 1817-1817
Open Access | Times Cited: 16

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance
Abdulaziz M. Eshaq, Thomas W. Flanagan, Sofie-Yasmin Hassan, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2754-2754
Open Access | Times Cited: 3

High expression of RBM8A predicts poor patient prognosis and promotes tumor progression in hepatocellular carcinoma
Rong Liang, Yan Lin, Jiazhou Ye, et al.
Oncology Reports (2017) Vol. 37, Iss. 4, pp. 2167-2176
Open Access | Times Cited: 28

Co-targeting of ACK1 and KIT triggers additive anti-proliferative and -migration effects in imatinib-resistant gastrointestinal stromal tumors
Wangzhen He, Liangliang Xu, Jiongyan Ding, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166690-166690
Open Access | Times Cited: 7

miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway
Zhendong Liu, Zhitao Liu, Yuanjun Zhang, et al.
Biochemical and Biophysical Research Communications (2017) Vol. 486, Iss. 2, pp. 211-217
Closed Access | Times Cited: 24

BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
Jing Yu, Ling Chen, Zhenhua Bao, et al.
Oncology Reports (2020)
Open Access | Times Cited: 14

Off-target pharmacological activity at various kinases: Potential functional and pathological side effects
Jonathon R. Green, Prathap Kumar S. Mahalingaiah, Sujatha M. Gopalakrishnan, et al.
Journal of Pharmacological and Toxicological Methods (2023) Vol. 123, pp. 107468-107468
Closed Access | Times Cited: 5

Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms
Chaolan Lv, Hongxiang Gu, Xinmei Zhao, et al.
Medical Science Monitor (2016) Vol. 22, pp. 4794-4802
Open Access | Times Cited: 12

Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1
Jinhong Zhu, Kui Cao, Meng Zhao, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 4

Hepatocyte Growth Factor-Dependent Antiviral Activity of Activated cdc42-Associated Kinase 1 Against Hepatitis B Virus
Hye Won Lee, Yongwook Choi, Ah Ram Lee, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 7

ACK1 is dispensable for development, skin tumor formation, and breast cancer cell proliferation
Rafael Oliveira Brandão, Mei Qi Kwa, Yossi Yarden, et al.
FEBS Open Bio (2021) Vol. 11, Iss. 6, pp. 1579-1592
Open Access | Times Cited: 6

Proximity-Dependent Biotinylation to Elucidate the Interactome of TNK2 Nonreceptor Tyrosine Kinase
Raiha Tahir, Anil K. Madugundu, Savita Udainiya, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 9, pp. 4566-4577
Open Access | Times Cited: 6

RON Mediates Tumor-Promoting Effects in Endometrial Adenocarcinoma
Qin Yu, Jianzhang Wang, Tiantian Li, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 5

WDR1 predicts poor prognosis and promotes cancer progression in hepatocellular carcinoma.
Linhui Zheng, Fang Hu, Jiaxi Li, et al.
PubMed (2018) Vol. 11, Iss. 12, pp. 5682-5693
Closed Access | Times Cited: 3

ACK1
Nobuyuki Takenaka, Takaya Satoh
Springer eBooks (2017), pp. 102-108
Closed Access

Page 1 - Next Page

Scroll to top